Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Goodwill (2016 - 2017)

IGC Pharma has reported Goodwill over the past 6 years, most recently at $198169.0 for Q4 2017.

  • Quarterly Goodwill changed 0.09% to $198169.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $198169.0 through Dec 2017, changed 0.09% year-over-year, with the annual reading at $198169.0 for FY2017, 83.22% down from the prior year.
  • Goodwill was $198169.0 for Q4 2017 at IGC Pharma, roughly flat from $198169.0 in the prior quarter.
  • Over five years, Goodwill peaked at $1.2 million in Q1 2016 and troughed at $198000.0 in Q4 2016.
  • The 4-year median for Goodwill is $982782.0 (2014), against an average of $695348.1.
  • Year-over-year, Goodwill rose 20.16% in 2016 and then crashed 83.22% in 2017.
  • A 4-year view of Goodwill shows it stood at $982782.0 in 2014, then changed by 0.0% to $982782.0 in 2015, then plummeted by 79.85% to $198000.0 in 2016, then rose by 0.09% to $198169.0 in 2017.
  • Per Business Quant, the three most recent readings for IGC's Goodwill are $198169.0 (Q4 2017), $198169.0 (Q3 2017), and $198169.0 (Q2 2017).